NIH Guide: Weekly Index for May 15, 2020

Funding Opportunities

• HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed)
  (PA-20-149)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
• Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed)
  (PA-20-151)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
• Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)
  (PA-20-201)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is June 12, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. If only AIDS applications are allowed replace text with Only accepting applications for the AIDS Application Due Date(s) listed below.
• Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
  (PA-20-202)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is June 12, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
  (PA-20-203)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is June 12, 2020.All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required)
  (PA-20-204)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is June 12, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
  (PA-20-205)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): May 7, 2024
• Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
  (PA-20-206)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is June 12, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
  (PAR-20-209)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): January 7, 2023
• NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
  (PAR-20-210)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 12, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Metastasis Research Network (U54 Clinical Trial Not Allowed)
  (RFA-CA-20-029)
  National Cancer Institute
  Application Receipt Date(s): September 28, 2020; May 28, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date..
• Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed)
  (RFA-DA-21-019)
  National Institute on Drug Abuse
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
• Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY) (U01 Clinical Trial Not Allowed)
  (RFA-DK-20-503)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): August 13, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
• Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01)
  (RFA-HS-20-003)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): June 15, 2020 All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research Program Award (R35 Clinical Trial Optional)
  (RFA-NS-20-030)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 31, 2020 No late applications will be accepted for this Funding Opportunity Announcement.